Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy por Walter Suárez Carmona | Ene 29, 2025
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials por Walter Suárez Carmona | Ene 29, 2025
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial por Walter Suárez Carmona | Ene 27, 2025
The role of incretin receptor agonists in the treatment of obesity por Walter Suárez Carmona | Ene 27, 2025
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial por Walter Suárez Carmona | Ene 27, 2025
